Intracellular metabolism of 99mTc-d,l-HMPAO in vitro: A basic approach for understanding the hyperfixation mechanism in damaged brain

Nuclear Medicine and Biology

Volumn 25, Issue 4, 1998, Pages 375-378

  Fujibayashi, Yasuhisa ^a,b   Taniuchi, Hideyuki ^a   Waki, Atsuo ^b   Yokoyama, Akira ^b   Ishii, Yasushi ^b   Yonekura, Yoshiharu ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

99mTc d,l hexamethylpropyleneamine oxime; Glutathione; Mitochondria; Redox; Thiol

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; THIOL DERIVATIVE; DODECYL SULFATE SODIUM; SURFACTANT;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN MITOCHONDRION; BRAIN PERFUSION; CELL FRACTIONATION; CONTROLLED STUDY; DRUG METABOLISM; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOSOL; DRUG EFFECT; HEAT; METABOLISM; SUBMITOCHONDRIAL PARTICLE;

ANIMALS; BRAIN INJURIES; CELLS, CULTURED; CYTOSOL; HEAT; MALE; MICE; SODIUM DODECYL SULFATE; SUBMITOCHONDRIAL PARTICLES; SURFACE-ACTIVE AGENTS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0031595428     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00221-7     Document Type: Article

References (17)

1. Ahn C. S., Tow D. E., Yu C. C., Greene R. W. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex. J. Cereb. Blood Flow Metab. 14:1994;324-331.
2. Babich J. W. Technetium-99m-HMPAO retention and the role of glutathione The debate continues . J. Nucl. Med. 32:1991;1681-1683.
3. 201Tl-DDC in rat brain. Nucl. Med. Commun. 10:1989;459-466.
4. el-Shirbiny A. M., Sadek S., Owunwanne A., Yacoub T., Suresh L., Abdel-Dayem H. M. Is TC-99m-hexamethylene propylene amine oxime uptake in the tissues related to glutathione cellular content? Nucl. Med. Commun. 10:1989;905-911.
5. 4-methylthiosemicarbazone) Cu-PTSM) by brain and tumor A novel radiopharmaceutical for positron emission tomography imaging . Ann. Nucl. Med. 9:1995;1-5.
6. 123I-iomazenil in acute herpes encephalitis. Neuroreport. 30:1995;1203-1206.
7. Mehler A. H., Kornberg A., Grisolia S., Ochoa S. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J. Biol. Chem. 174:1948;961-977.
8. Neirinckx R. D., Canning L. R., Piper I. N., Nowotnik D. P., Pickett R. D., Holmes R. A., Volkert W. A., Foster A. M., Weisner P. S., Marriott J. A., Chaplin S. B. Technetium-99m d,l-HMPAO A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion . J. Nucl. Med. 28:1987;191-202.
9. Neirinckx R. D., Burke J. F., Harrison R. C., Forster A. M., Andersen A. R., Lassen N. A. The retention mechanism of technetium-99m-HM-PAO Intracellular reaction with glutathione . J. Cereb. Blood Flow Metab. 8:(suppl I):1988;S4-S12.
10. Papatheofanis F. J., Shirazi P., Gupta S. Tc-99m HMPAO hyperfixation and reversal on cerebral SPECT imaging after subacute ischemic infarction. Clin. Nucl. Med. 20:1995;82-83.
11. Reichelt K. L., Fonnum F. Subcellular localization of N-acetyl-aspartyl-glutamate, N-acetyl-glutamate and glutathione in brain. J. Neurochem. 16:1969;1409-1416.
12. Rowell N. P., McCready V. R., Cronin B., Pepper J., Higley B., Burke J. F., Tyrrell D. A. Tc-99m-labelled meso-HMPAO and glutathione content of human lung tumours. Nucl. Med. Commun. 10:1989;503-508.
13. Shintani S., Tsuruoka S., Satoh Y. Spurious hyperfixation of hexamethylpropylamine oxime in acute embolic stroke. Am. J. Neuroradiol. 16:1995;1532-1535.
14. 99mTc-HMPAO imaging . Ann. Nucl. Med. 9:1995;161-166.
15. Sperling B., Lassen N. A. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT. Stroke. 24:1993;193-194.
16. Suess E., Juck S., Reither H., Hörtnagl H., Angelberger P. Uptake mechanism of technetium-99m-d,l-HMPAO in cell cultures of the dissociated postnatal rat cerebellum. J. Nucl. Med. 33:1992;108-114.
17. 4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by Complex I in brain mitochondria A potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET) . Biol. Pharm. Bull. 18:1995;1126-1129.